{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:13:50Z","timestamp":1789524830734,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI125623"],"award-info":[{"award-number":["R01AI125623"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI148366"],"award-info":[{"award-number":["R01AI148366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI162670"],"award-info":[{"award-number":["R01AI162670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM143223"],"award-info":[{"award-number":["R01GM143223"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56AI146434"],"award-info":[{"award-number":["R56AI146434"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.mucimm.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:24:23Z","timestamp":1704961463000},"page":"169-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection"],"prefix":"10.1016","volume":"17","author":[{"given":"Saugata","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir Noor","family":"Nafiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6421-1184","authenticated-orcid":false,"given":"Hazel","family":"Dellario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"3rd","given":"Roy","family":"Curtiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6856-2737","authenticated-orcid":false,"given":"Yoichi","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6541-9513","authenticated-orcid":false,"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2024.01.002_b0005","unstructured":"Centers for Disease Control and Prevention. Pneumococcal disease. Available at: https:\/\/www.cdc.gov\/pneumococcal\/index.html [Date accessed: 15 June 2019]."},{"key":"10.1016\/j.mucimm.2024.01.002_b0010","doi-asserted-by":"crossref","first-page":"e00107","DOI":"10.1128\/CMR.00107-18","article-title":"Host-Pathogen interactions in Gram-positive bacterial pneumonia","volume":"32","author":"Grousd","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mucimm.2024.01.002_b0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2024.01.002_b0020","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.mucimm.2024.01.002_b0025","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.01.002_b0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(58)92404-8","article-title":"Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza","volume":"2","author":"Hers","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.mucimm.2024.01.002_b0035","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/infdis\/jit008","article-title":"Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia","volume":"207","author":"Fleming-Dutra","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.01.002_b0040","first-page":"27","article-title":"A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.mucimm.2024.01.002_b0045","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1016\/j.vaccine.2017.09.005","article-title":"The impact of 10-valent and 13-valent Pneumococcal Conjugate Vaccines on hospitalization for pneumonia in children: a systematic review and meta-analysis","volume":"35","author":"Alicino","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/vaccines9030209","article-title":"Multi-valent protein hybrid pneumococcal vaccines: a strategy for the next generation of vaccines","volume":"9","author":"Scott","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mucimm.2024.01.002_b0055","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.vaccine.2015.04.025","article-title":"Safety, tolerability, and immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in healthy adults","volume":"33","author":"McFetridge","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0060","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1080\/21645515.2020.1863177","article-title":"A randomized phase 1 study of the safety and immunogenicity of 2 novel Pneumococcal Conjugate Vaccines in healthy Japanese adults in the United States","volume":"17","author":"Fitz-Patrick","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.mucimm.2024.01.002_b0065","doi-asserted-by":"crossref","first-page":"18977","DOI":"10.1038\/s41598-020-75691-5","article-title":"Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency","volume":"10","author":"L\u00f8chen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2024.01.002_b0070","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.mucimm.2024.01.002_b0075","article-title":"Magnetic bead-based separation of pneumococcal serotypes","volume":"3","author":"York","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.mucimm.2024.01.002_b0080","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1128\/iai.58.10.3293-3299.1990","article-title":"Pneumococcal surface protein A (Pspa) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae","volume":"58","author":"Crain","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.826264","article-title":"A jack of all trades: the role of pneumococcal surface protein A in the pathogenesis of Streptococcus pneumoniae","volume":"12","author":"Lane","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0090","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1128\/iai.59.1.222-228.1991","article-title":"Pspa, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type","volume":"59","author":"Mcdaniel","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0095","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/IAI.01623-07","article-title":"Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis","volume":"76","author":"Xin","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20071168","article-title":"Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies","volume":"205","author":"Giefing","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2024.01.002_b0105","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0264-410X(99)00530-7","article-title":"Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules","volume":"18","author":"Nabors","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0110","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"Hollingshead","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/vaccines7040146","article-title":"Evaluation of pneumococcal surface protein A as a vaccine antigen against secondary Streptococcus pneumoniae challenge during influenza A infection","volume":"7","author":"Roberts","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mucimm.2024.01.002_b0120","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/pharmaceutics14061238","article-title":"Pneumococcal surface protein A-hybrid nanoparticles protect mice from lethal challenge after mucosal immunization targeting the lungs","volume":"14","author":"Figueiredo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mucimm.2024.01.002_b0125","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2015.03.010","article-title":"Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization","volume":"33","author":"Kuipers","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/IAI.00950-10","article-title":"Immunization with Salmonella enterica serovar Typhimurium-Derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae","volume":"79","author":"Muralinath","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0135","article-title":"Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.1016\/j.mucimm.2024.01.002_b0140","doi-asserted-by":"crossref","first-page":"e0069921","DOI":"10.1128\/mSphere.00699-21","article-title":"Outer membrane vesicles displaying a heterologous PcrV-HitA fusion antigen promote protection against pulmonary Pseudomonas aeruginosa infection","volume":"6","author":"Li","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.mucimm.2024.01.002_b0145","first-page":"e2307066","article-title":"Pneumonic plague protection induced by a monophosphoryl lipid A decorated Yersinia outer-membrane-vesicle vaccine","author":"Majumder","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.mucimm.2024.01.002_b0150","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/jb.90.6.1520-1524.1965","article-title":"Mouse C-reactive protein and endotoxin-induced resistance","volume":"90","author":"Patterson","year":"1965","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.vaccine.2004.05.035","article-title":"Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation","volume":"23","author":"Posthouwer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0160","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/jiv066","article-title":"Limited efficacy of antibacterial vaccination against secondary Serotype 3 pneumococcal pneumonia following influenza infection","volume":"212","author":"Metzger","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.01.002_b0165","doi-asserted-by":"crossref","first-page":"e1003238","DOI":"10.1371\/journal.ppat.1003238","article-title":"Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae","volume":"9","author":"Smith","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mucimm.2024.01.002_b0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20011576","article-title":"The immune response to pneumococcal proteins during experimental human carriage","volume":"195","author":"McCool","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2024.01.002_b0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0180","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.201212-2277OC","article-title":"Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults","volume":"187","author":"Ferreira","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mucimm.2024.01.002_b0185","doi-asserted-by":"crossref","first-page":"e25558","DOI":"10.1371\/journal.pone.0025558","article-title":"Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation","volume":"6","author":"Cohen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mucimm.2024.01.002_b0190","doi-asserted-by":"crossref","first-page":"e0154616","DOI":"10.1371\/journal.pone.0154616","article-title":"Generation and improvement of effector function of a novel broadly reactive and protective monoclonal antibody against pneumococcal surface protein A of Streptococcus pneumoniae","volume":"11","author":"Kristian","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mucimm.2024.01.002_b0195","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","article-title":"Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections","volume":"191","author":"Ghoneim","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.894644","article-title":"Neutrophil recruitment in pneumococcal pneumonia","volume":"12","author":"Palmer","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0205","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.12170","article-title":"Alveolar macrophages in pulmonary host defence the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing","volume":"174","author":"Aberdein","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0210","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.2000094","article-title":"Influenza infection induces alveolar macrophage dysfunction and thereby enables noninvasive Streptococcus pneumoniae to cause deadly pneumonia","volume":"205","author":"Verma","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0215","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1128\/IAI.00433-10","article-title":"Naturally produced outer membrane vesicles from Pseudomonas aeruginosa elicit a potent innate immune response via combined sensing of both lipopolysaccharide and protein components","volume":"78","author":"Ellis","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0220","doi-asserted-by":"crossref","first-page":"e71751","DOI":"10.1371\/journal.pone.0071751","article-title":"Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins","volume":"8","author":"Jun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mucimm.2024.01.002_b0225","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by toll-like receptor 6","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/CVI.00561-13","article-title":"Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens","volume":"21","author":"Nagaputra","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0235","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.vaccine.2004.08.002","article-title":"Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents","volume":"23","author":"Theeten","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0240","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2019.00358","article-title":"Mechanisms of naturally acquired immunity to Streptococcus pneumoniae","volume":"10","author":"Ramos-Sevillano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0245","doi-asserted-by":"crossref","first-page":"e00916","DOI":"10.1128\/IAI.00916-17","article-title":"Comparison of immunogenicity and protection of two pneumococcal protein vaccines based on PsaA and PspA","volume":"86","author":"Yu","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0250","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.4049\/jimmunol.1000831","article-title":"Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae","volume":"185","author":"Fukuyama","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0255","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.173.7.4576","article-title":"An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage","volume":"173","author":"Sun","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.781280","article-title":"An intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection","volume":"12","author":"van der Ley","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0265","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.vaccine.2009.12.058","article-title":"Quantitative analysis of influenza virus-specific B cell memory generated by different routes of inactivated virus vaccination","volume":"28","author":"Joo","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.01.002_b0270","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/16000617.00002515","article-title":"Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments","volume":"24","author":"Lai","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.mucimm.2024.01.002_b0275","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2024.01.002_b0280","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41590-019-0568-x","article-title":"Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection","volume":"21","author":"Aegerter","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0285","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mucimm.2024.01.002_b0290","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.cell.2018.09.042","article-title":"Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity","volume":"175","author":"Yao","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2024.01.002_b0295","doi-asserted-by":"crossref","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mucimm.2024.01.002_b0300","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1128\/iai.65.7.2975-2977.1997","article-title":"Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia","volume":"65","author":"Rubins","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0305","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jix090","article-title":"Reduced T-helper 17 responses to Streptococcus pneumoniae in infection-prone children can be rescued by addition of innate cytokines","volume":"215","author":"Basha","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.01.002_b0310","doi-asserted-by":"crossref","first-page":"e1003727","DOI":"10.1371\/journal.ppat.1003727","article-title":"Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung","volume":"9","author":"LeMessurier","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mucimm.2024.01.002_b0315","doi-asserted-by":"crossref","first-page":"e03589","DOI":"10.1128\/mBio.03589-20","article-title":"Type I interferon signaling is a common factor driving Streptococcus pneumoniae and influenza A virus shedding and transmission","volume":"12","author":"Zangari","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.mucimm.2024.01.002_b0320","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.2101135","article-title":"Type I IFN signaling is essential for preventing IFN-gamma hyperproduction and subsequent deterioration of antibacterial immunity during postinfluenza pneumococcal infection","volume":"209","author":"Palani","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.01.002_b0325","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/513980","article-title":"Intranasal immunization of mice with PspA (Pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae","volume":"175","author":"Wu","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.01.002_b0330","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1128\/IAI.00486-09","article-title":"PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae","volume":"77","author":"Xin","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0335","doi-asserted-by":"crossref","first-page":"e01335","DOI":"10.1128\/mBio.01335-19","article-title":"Allergic airway disease prevents lethal synergy of influenza A virus-Streptococcus pneumoniae Coinfection","volume":"10","author":"Roberts","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.mucimm.2024.01.002_b0340","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/IAI.06348-11","article-title":"Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury","volume":"80","author":"Salha","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.mucimm.2024.01.002_b0345","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.2200487","article-title":"Lung resident memory T cells activated by oral vaccination afford comprehensive protection against pneumonic Yersinia pestis infection","volume":"210","author":"Singh","year":"2023","journal-title":"J. Immunol."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T08:06:37Z","timestamp":1729065997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021924000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1933021924000023"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.01.002","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}